Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAINT I: NXY-059 in Acute Ischemic Stroke
NCT00119626Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2003
- Primary completion
- Feb 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of OKN-007 in ischemic stroke, sponsored by AstraZeneca. Started Jun 2003; status: completed.
02
Drugs
OKN-007
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00119626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00119626.